Vimta Labs Share Price

Vimta Labs Share Price

NSE: VIMTALABS
|
Pharmaceuticals
|
S Cap
₹ 609.85
-₹0.30 (-0.05%)
1D
Last updated 23 Sep, 2026, 14:32 IST

Vimta Labs Share Price Today

As of 23 Sep 2026, Vimta Labs share price is ₹609.85. The stock opened at ₹612.50, compared to its previous close of ₹610.15. During today's trading session, Vimta Labs share price moved in the range of ₹606.75 to ₹619.00, with an average price of ₹612.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹376.05 and a high of ₹828.35. On the performance front, Vimta Labs share price has increased by 42.83% over the last six months and is down 20.16% on a year-on-year basis.

₹606.75
0.05% down today
₹619.00
1D LOW
1D HIGH

Vimta Labs Returns Calculator

Circuit
L
H
₹488.15
₹732.15
52-week
L
H
₹376.05
₹828.35

About Vimta Labs

Vimta Labs Share Price
ISIN
INE579C01029
Sector Market Cap
₹ 2,137.65 Cr

Vimta Labs Limited is contract research and testing services provider in India. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; and environmental regulatory services, such as impact assessments and post project monitoring to various industries, such as power, infrastructure, and others.

Vimta Labs Financial Highlights

  • Revenue: Vimta Labs reported revenue of ₹292.31 crore in FY24 vs ₹321.63 crore in FY23. It showed a decrease of 9.12% on a yearly basis.
  • Operating Profit: Vimta Labs reported an operating profit of ₹62.50 crore in FY24 vs ₹65.00 crore in FY23. It showed a decrease of 3.85% on a year-on-year basis.
  • Net Profit: Vimta Labs reported a net profit of ₹41.01 crore in FY24 vs ₹48.17 crore in FY23. It showed a decrease of 14.86% on a yearly basis.

Vimta Labs Quarterly Result Highlights

  • Vimta Labs reported revenue of ₹91.15 crore in Dec 2024, compared with ₹85.42 crore in Sep 2024, representing an increase of 6.71% on a quarter-on-quarter (QoQ) basis.
  • Vimta Labs reported an operating profit of ₹23.92 crore in Dec 2024, compared with ₹21.89 crore in Sep 2024, representing an increase of 9.27% on a quarter-on-quarter (QoQ) basis.
  • Vimta Labs reported a profit of ₹21.50 crore in Dec 2024, compared with ₹15.25 crore in Sep 2024, reflecting an increase of 40.98% on a QoQ basis.
  • The earnings per share (EPS) of Vimta Labs stood at ₹18.51 during Dec 2024.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
35.67%
FII
4.42%
Other DII
0.17%
Retail and other
59.55%
Mutual funds
0.20%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20254.33%
Dec 20254.59%
Mar 20264.89%
Jun 20264.42%
Mkt Cap Cr
2,137.65
P/E
34.83
P/B
6.24
ROE
14.59%
D/E
0.01
ROCE
19.04%
Div. Yield
0.32%
EPS(TTM)
17.40
Turnover
0.74
EV/EBITDA
18.28
Net Margin
19.03%
Op. Margin
36.56%
ROA
13.94%
Quick Ratio
2.97
Curr. Ratio
3.53
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Vimta Labs outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Vimta Labs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Vimta Labs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,27,792.0058.8413.4820.48%0.3217.27%692.920.23%0.66103.81
Max Healthcare1,03,069.0070.749.5913.42%0.0912.97%91.840.19%0.277.37
MANIPAL HEALTH ENTERPRI L98,160.00108.315.9810.59%0.009.51%100.510.00%0.000.00
Fortis Healthcare67,512.1063.066.8210.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare65,493.10180.6115.578.48%0.3110.10%49.230.24%0.435.20
Global Health39,996.0072.4210.1014.05%0.0615.26%149.240.03%0.7318.46
Narayana Hrudayalaya38,480.1047.128.4817.76%0.7611.42%127.100.24%0.7624.77
KRISHNA INST OF MED SCI L33,199.40170.728.8610.74%0.637.99%93.540.00%0.426.52
Dr. Lal Path Labs32,076.8058.7112.7920.13%0.0825.56%147.341.07%0.9130.45
Poly Medicure17,223.8055.055.5510.37%0.0812.71%301.170.21%0.4833.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Vimta Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Revenue₹318.26₹318.19₹278.28₹210.68
Other Income₹4.01₹3.44₹1.45₹0.83
Total Revenue₹322.27₹321.63₹279.73₹211.51
Total Expenses₹267.79₹256.64₹222.82₹182.97
Profit Before Tax₹54.48₹65.00₹55.69₹28.54
Tax₹13.47₹16.83₹14.36₹7.14
Profit After Tax₹41.01₹48.17₹41.33₹21.41
EPS - Basic₹18.51₹21.77₹18.70₹9.68
EPS - Diluted₹18.24₹21.35₹18.32₹9.68

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Profit before tax₹54.48₹65.00₹55.69₹28.54
Income before WC changes₹91.75₹104.11₹87.07₹57.77
Change in Assets-₹11.53-₹15.46-₹15.26-₹19.81
Change in Liabilities-₹3.85₹11.82₹3.90₹6.43
Change in WC-₹15.38-₹3.64-₹11.36-₹13.38
Cash flow from Operations₹60.89₹87.94₹59.07₹37.18
Cash flow from Investing-₹76.05-₹57.26-₹37.85-₹31.92
Cash flow from Financing-₹1.90-₹10.98-₹16.61-₹4.57
Total Cash Flow-₹17.06₹19.70₹4.61₹0.69
Cash (Start of the year)₹30.50₹10.80₹6.19₹5.51
Cash (End of the year)₹13.44₹30.50₹10.80₹6.19

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Non-Current Assets₹242.45₹198.67₹182.84₹163.82
Current Assets₹157.60₹163.66₹124.36₹110.54
Total Assets₹400.05₹362.33₹307.20₹274.36
Current Liabilities₹54.07₹57.28₹47.75₹53.91
Net Current Asset₹103.53₹106.38₹76.61₹56.63
Non-Current Liabilities₹26.28₹23.26₹25.47₹26.06
Equity Capital₹319.70₹281.79₹233.98₹194.38
Total Equity & Liabilities₹400.05₹362.33₹307.20₹274.36

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹407.29₹343.98₹288.60₹315.12
Other Income₹8.99₹4.24₹3.71₹3.47
Total Revenue₹416.28₹348.22₹292.31₹318.58
Total Expenses₹310.71₹259.22₹229.80₹254.75
Profit Before Tax₹103.95₹89.00₹62.50₹63.83
Tax₹26.44₹22.25₹13.69₹16.53
Profit After Tax₹77.51₹66.76₹48.81₹47.30
EPS - Basic₹17.40₹30.28₹18.51₹21.37
EPS - Diluted₹17.20₹29.86₹18.24₹20.96

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹103.95₹90.41₹54.48₹63.83
Income before WC changes₹154.65₹124.06₹91.75₹102.74
Change in Assets-₹7.75-₹25.01-₹11.53-₹15.45
Change in Liabilities₹23.91₹17.02-₹3.85₹11.45
Change in WC₹16.16-₹7.99-₹15.38-₹3.99
Cash flow from Operations₹147.14₹94.05₹60.89₹86.51
Cash flow from Investing-₹129.67-₹75.54-₹76.05-₹56.93
Cash flow from Financing-₹10.35-₹16.12-₹1.90-₹10.66
Total Cash Flow₹7.12₹2.40-₹17.06₹18.92
Cash (Start of the year)₹15.84₹13.44₹30.50₹10.65
Cash (End of the year)₹22.97₹15.84₹13.44₹29.57

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹337.36₹278.72₹236.87₹197.69
Current Assets₹224.87₹187.82₹157.60₹162.78
Total Assets₹562.23₹466.53₹394.47₹360.47
Current Liabilities₹65.52₹64.37₹54.07₹56.74
Net Current Asset₹159.35₹123.45₹103.53₹106.03
Non-Current Liabilities₹39.83₹23.32₹26.28₹23.15
Equity Capital₹456.87₹378.85₹314.12₹280.58
Total Equity & Liabilities₹562.23₹466.53₹394.47₹360.47
* All values are in INR Crore
Qty
Bid
15
610.1
15
610.05
26
610
8
609.9
10
609.85
Ask
Qty
610.75
10
610.9
29
610.95
48
611
56
611.05
30
Bid Total: 74
Ask Total: 173
Buy orders: 30%
Sell orders: 70%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
45.85
Neutral
ATR (14)
22.2
Neutral
STOCH(9,6)
48.63
Neutral
STOCH RSI (14)
26.16
Neutral
ADX(9)
23.76
Bearish
UO(9)
35.9
Neutral
ROC(12)
-6.45
Bearish
WillR(14)
-67.23
Neutral
Period
Simple value
Exponential vaue
5D
605.47
610.84
10D
616.18
615.79
20D
626.89
620.72
50D
615.36
608.84
100D
566.72
579.26
Volume trend — traded volume by day
23 Sep1L
22 Sep1L
21 Sep2L
18 Sep0L
17 Sep1L
16 Sep2L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Vimta Labs Share Price
Vimta Labs
Pharmaceuticals
Add Stock
Add Another

Vimta Labs Share Price FAQs

Vimta Labs share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837